Home › Funds › Boxer Capital Management, LLC › PTCT
Boxer Capital Management, LLC position in PTCT
PTC THERAPEUTICS INC · Health Care
Boxer Capital Management, LLC reported holding 200,000 shares of PTCT (PTC THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$16.3M, representing 1.23% of its reported portfolio and ranking #20 among its reported holdings. Boxer Capital Management, LLC has disclosed PTCT holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Boxer Capital Management, LLC's PTCT position evolved
Boxer Capital Management, LLC first disclosed a stake in PTCT in Q3 2025 at 200,000 shares (US$12.3M). The position peaked in Q2 2026 at 200,000 shares, worth US$16.3M. Across 4 filings, Boxer Capital Management, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 200,000 shares valued at US$16.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 200.00K | $12.27M | New |
| Q4 2025 | 200.00K | $15.19M | Hold |
| Q1 2026 | 200.00K | $13.63M | Hold |
| Q2 2026 | 200.00K | $16.31M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PTCT and 13F data
PTCT (PTC THERAPEUTICS INC) is a Health Care company. 55 other funds we track also report a position in PTCT — the largest reported positions include RTW INVESTMENTS, LP (US$631.9M), TORONTO DOMINION BANK (US$176.7M), WESTFIELD CAPITAL MANAGEMENT CO LP (US$159.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PTCT
- RTW INVESTMENTS, LP 7.75M sh · $631.88M · Q2 2026
- TORONTO DOMINION BANK 2.17M sh · $176.67M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.96M sh · $159.56M · Q2 2026
- Hood River Capital Management LLC 1.74M sh · $141.82M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.50M sh · $122.36M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.44M sh · $117.47M · Q2 2026
- Jefferies Financial Group Inc. 1.36M sh · $110.69M · Q2 2026
- Blue Sparrow, LLC /DE 1.05M sh · $85.71M · Q2 2026
- Palo Alto Investors LP 918.85K sh · $74.95M · Q2 2026
- ARMISTICE CAPITAL, LLC 660.00K sh · $53.84M · Q2 2026
- Parkman Healthcare Partners LLC 435.69K sh · $35.54M · Q2 2026
- Defilade Capital Management, L.P. 433.70K sh · $35.38M · Q2 2026
More on Boxer Capital Management, LLC
FAQ
How long has Boxer Capital Management, LLC held PTCT?
Boxer Capital Management, LLC has disclosed PTCT holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Boxer Capital Management, LLC's current position in PTCT?
As of Q2 2026, Boxer Capital Management, LLC holds 200.00K shares of PTCT (PTC THERAPEUTICS INC), valued at $16.31M, representing 1.23% of its reported portfolio and ranking #20.
Has Boxer Capital Management, LLC been buying or selling PTCT?
In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC held unchanged its position in PTCT. The position peaked in Q2 2026 at 200.00K shares.
Which other funds hold PTCT?
Other major institutional holders of PTCT include RTW INVESTMENTS, LP, TORONTO DOMINION BANK, WESTFIELD CAPITAL MANAGEMENT CO LP, among 55 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.